All OpportunitiesView on Grants.gov
HHS-FDA
FOR-FD-25-009
discretionary
Forecasted
Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
Food and Drug AdministrationPosted August 14, 2024
Official Federal Notice
View the complete notice on Grants.gov
Summary
To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures for clinical trials in stimulant use disorders, assessment of opioid clinical trials with active control in addition to placebo, neurodevelopmental outcome assessment of vulnerable pediatric patients exposed to anesthesia and opioid, and a living systematic review of...
Read full notice on Grants.govEligible Applicants
- Unrestricted
- Nonprofits (501(c)(3))
- State governments
- Other tribal organizations
- Federally recognized tribal governments
- County governments
- Nonprofits (non-501(c)(3))
- Public And Indian Housing Authorities
- Special district governments
- Private institutions of higher education
- Small businesses
- City or township governments
- Public institutions of higher education
- For-profit organizations
- Independent school districts
Assistance Listings
93.103
Food and Drug Administration ResearchFunding Instrument
Cooperative Agreement
CFDA / Assistance Listing Numbers
93.103
Topics
Program Contact
Information on this page is sourced from official federal notices on Grants.gov. Always verify eligibility, deadlines, and requirements using the official notice. Funding Radar is not affiliated with the U.S. government.
Key Details
Award Ceiling
$2,000,000
Award Floor
$2,000,000
Expected Awards
5
Posted
August 14, 2024
Cost Sharing
Not Required
Agency
HHS-FDA
Data from Grants.gov
Last fetched: 3/23/2026